Shaanxi Key Laboratory of Natural Products & Chemical Biology, School of Chemistry & Pharmacy, Northwest A&F University, Yangling 712100, China; Department of Natural Medicine & Institute of Materia Medica, School of Pharmacy, Fourth Military Medical University, Xi'an 710032,China; Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Xi'an 710032,China.
Department of Natural Medicine & Institute of Materia Medica, School of Pharmacy, Fourth Military Medical University, Xi'an 710032,China.
Int J Biol Macromol. 2019 Jan;121:161-172. doi: 10.1016/j.ijbiomac.2018.09.213. Epub 2018 Oct 2.
A new water-soluble polysaccharide, APS-1II, with a molecular weight of 42.1 kDa was isolated from the roots of Angelica sinensis (Oliv.) Diels. APS-1II consists of arabinose (Ara), glucose (Glc) and fucose (Fuc) with a molar ratio of 2.48:1.05:1.00. The backbone of APS-1II is composed of 1,3-α-l-Araf and 1,6-α-d-Glcp with the branches containing 1,5-α-l-Araf, 1,4-β-d-Glcp, T-β-d-Glcp, 1,3-α-l-Fucp and T-α-l-Fucp. APS-1II inhibited the proliferation of human leukemia K562 and mouse L1210 cells in vitro and markedly prolonged the life span of L1210-bearing mice in vivo. APS-1II also increased the numbers of leukocytes and lymphocytes in peripheral blood, and significantly decreased plasma tumor necrosis factor, interleukin-2 and interferon-γ levels in L1210-bearing mice. Moreover, APS-1II administration concentration-dependently promoted the proliferation of the splenocytes, enhanced phagocytic activity of peritoneal macrophages and cytotoxicity of natural killer cells. These results suggest that APS-1II could effectively inhibit leukemia and induce a protective immune response, and it may be used as a suitable candidate reagent for leukemia therapy.
一种新的水溶性多糖 APS-1II,分子量为 42.1kDa,从当归(Oliv.)Diels 的根部分离得到。APS-1II 由阿拉伯糖(Ara)、葡萄糖(Glc)和岩藻糖(Fuc)组成,摩尔比为 2.48:1.05:1.00。APS-1II 的骨架由 1,3-α-l-Araf 和 1,6-α-d-Glcp 组成,支链含有 1,5-α-l-Araf、1,4-β-d-Glcp、T-β-d-Glcp、1,3-α-l-Fucp 和 T-α-l-Fucp。APS-1II 体外抑制人白血病 K562 和小鼠 L1210 细胞的增殖,并显著延长荷 L1210 小鼠的存活期。APS-1II 还增加外周血白细胞和淋巴细胞的数量,并显著降低荷 L1210 小鼠血浆肿瘤坏死因子、白细胞介素-2 和干扰素-γ水平。此外,APS-1II 给药呈浓度依赖性促进脾细胞增殖,增强腹腔巨噬细胞的吞噬活性和自然杀伤细胞的细胞毒性。这些结果表明,APS-1II 可有效抑制白血病并诱导保护性免疫反应,可能作为白血病治疗的合适候选试剂。